Cyclin-dependent kinase 12, a novel drug target for visceral leishmaniasis

Visceral leishmaniasis (VL) causes significant mortality and morbidity in many parts of the world. There is an urgent need for the development of new, effective treatments for this disease. We describe the development of a novel anti-leishmanial drug-like chemical series based on a pyrazolopyrimidin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wyllie, Susan, Thomas, Michael, Patterson, Stephen, Crouch, Sabrinia, De Rycker, Manu, Lowe, Rhiannon, Gresham, Stephanie, Urbaniak, Michael D., Otto, Thomas D., Stojanovski, Laste, Simeons, Frederick, Manthri, Sujatha, MacLean, Lorna M., Zuccotto, Fabio, Homeyer, Nadine, Pflaumer, Hannah, Boesche, Markus, Sastry, Lalitha, Connolly, Paul, Albrecht, Sebastian, Berriman, Matt, Drewes, Gerard, Gray, David W., Ghidelli-Disse, Sonja, Dixon, Susan, Fiandor, Jose M., Wyatt, Paul G., Ferguson, Michael A. J., Fairlamb, Alan H., Miles, Timothy J., Read, Kevin D., Gilbert, Ian H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402543/
https://www.ncbi.nlm.nih.gov/pubmed/30046105
http://dx.doi.org/10.1038/s41586-018-0356-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402543/
https://www.ncbi.nlm.nih.gov/pubmed/30046105
http://dx.doi.org/10.1038/s41586-018-0356-z

Ejemplares similares